About us

Orama Therapeutics was established to develop novel therapies for ophthalmic diseases that address the underlying inflammatory processes, thus providing a more meaningful clinical benefit for patients.

Orama has assembled a nimble, highly experienced team with global ophthalmology experience.

World-class team with deep experience

Steve Harris Chairman and acting CFO
Darren Mercer Chief Executive Officer
Dr Rod Hafner Chief Development Officer
Houman Hemmati, MD, PhD Chief Medical Advisor
Volkmar Nass Chief Commercial Officer
Peter Adamson Chief Scientific Advisor